No party, no drugs? Use of stimulants, dissociative drugs, and GHB/GBL during the early COVID-19 pandemic.
International Journal of Drug Policy April 1, 2022 Antonia Bendau, Leonard Viohl, Moritz Bruno Petzold et al.
The COVID-19 pandemic is presumably having an impact on the consumption of psychoactive substances. Social distancing and lockdown measures may particularly affect the use of "party drugs" (e.g., stimulants, dissociatives, and GHB/GBL) through the absence of typical use settings. We aimed to analyse the use patterns of those substances and underlying motivations before and during the pandemic....
DOI: 10.1016/j.drugpo.2022.103582 (opens in new tab)
Full text (opens in new tab)
Ketamine
MDMA
Amphetamine
Cocaine
+2